Michael Gibson

Dr. Gibson is an Associate Professor of Medicine at the Vanderbilt University, Vanderbilt-Ingram Cancer Center, where he is Director of Translational Research for Head and Neck Oncology. After obtaining his MD from Johns Hopkins, he completed an Osler Medical Residency and Medical Oncology Fellowship at Johns Hopkins Hospital while concurrently earning a PhD in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He currently leads local and national therapeutic trials for aero-digestive cancers, all with translational laboratory components. The overall goals of his research efforts are to bring novel therapeutics to the treatment of aero-digestive cancers based on rational pre-clinical investigation and in the setting of a focus on patient safety and outcomes.